Clinical trial
The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development
NCT03111927 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 13, 2017
- Completion date
- February 28, 2022
- Enrollment
- 189 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, infant development